Literature DB >> 19765829

Cognitive deficits in the euthymic phase of unipolar depression.

Marek Preiss1, Hana Kucerova, Jiri Lukavsky, Hana Stepankova, Petr Sos, Radka Kawaciukova.   

Abstract

Although neuropsychological deficits have been reported in patients with major depressive disorder (MDD) during an acute episode, relatively little is known about the persistence of these deficits in remission. This study investigated the performance of attention, executive function and verbal memory during remission from unipolar depressive episodes. We tested the hypothesis that outpatients do not differ in cognitive variables from controls. We did this using a well-defined outpatient sample, consisting of medicated and unmedicated patients, with a history of MDD. Ninety-seven subjects with MDD in remission ranging from young to old were compared with 97 healthy control subjects. Both samples were balanced for age, gender, and education levels. The Auditory Verbal Learning Test (AVLT) and the Trail Making Test (TMT) were used. Patients with remitted MDD, in comparison with controls, were impaired on tasks of attention, executive function and verbal memory. The individual level of depressive symptoms was not related to the cognitive performance. Small- to medium-sized significant correlations exist between cognitive test variables (as represented by Trail Making B and AVLT delayed recall) and level of depressive symptomatology (as measured by MADRS or BDI-II) in the total sample, indicating that higher levels of depressive symptomatology are associated with lower cognitive function. These findings suggest deficits in attention and delayed verbal recall can serve as an indicator for MDD in outpatients.

Entities:  

Mesh:

Year:  2009        PMID: 19765829     DOI: 10.1016/j.psychres.2008.06.042

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  22 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 2.  Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Psychopharmacology (Berl)       Date:  2011-09-23       Impact factor: 4.530

3.  [Minimal emotional dysfunction and first impression formation in personality disorders].

Authors:  M Linden; M Vilain
Journal:  Nervenarzt       Date:  2011-01       Impact factor: 1.214

Review 4.  Systematic review of the neural basis of social cognition in patients with mood disorders.

Authors:  Andrée M Cusi; Anthony Nazarov; Katherine Holshausen; Glenda M Macqueen; Margaret C McKinnon
Journal:  J Psychiatry Neurosci       Date:  2012-05       Impact factor: 6.186

Review 5.  Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state.

Authors:  Dominik Kriesche; Christian F J Woll; Nadja Tschentscher; Rolf R Engel; Susanne Karch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-01       Impact factor: 5.760

6.  Depression and episodic memory across the adult lifespan: A meta-analytic review.

Authors:  Taylor A James; Samuel Weiss-Cowie; Zachary Hopton; Paul Verhaeghen; Vonetta M Dotson; Audrey Duarte
Journal:  Psychol Bull       Date:  2021-11       Impact factor: 23.027

7.  Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol.

Authors:  Saray Monzón; Margalida Gili; Margalida Vives; Maria Jesus Serrano; Natalia Bauza; Rosa Molina; Mauro García-Toro; Joan Salvà; Joan Llobera; Miquel Roca
Journal:  BMC Psychiatry       Date:  2010-06-17       Impact factor: 3.630

8.  Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: a monozygotic discordant twin-pair study.

Authors:  Kean J Hsu; Kelly C Young-Wolff; Kenneth S Kendler; Lisa J Halberstadt; Carol A Prescott
Journal:  Psychiatry Res       Date:  2013-11-05       Impact factor: 3.222

9.  Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.

Authors:  Manisha Madhoo; Richard S E Keefe; Robert M Roth; Angelo Sambunaris; James Wu; Madhukar H Trivedi; Colleen S Anderson; Robert Lasser
Journal:  Neuropsychopharmacology       Date:  2013-12-06       Impact factor: 7.853

Review 10.  Cognitive mechanisms of treatment in depression.

Authors:  Jonathan P Roiser; Rebecca Elliott; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.